“We have always said that we would cordially welcome anyone who requests registration from the European (Medicines) Agency.
I talked about this with the Russian president, we saw good data on the Russian vaccine today, "RIA Novosti Merkel quotes.
She stated that "any vaccine is welcomed in the European Union, but only those that provide the EMA (European Medicines Agency) with the necessary data will be allowed."
Earlier it was reported that the scientific journal The Lancet published the results of the third phase of clinical trials of the Russian vaccine against coronavirus infection COVID-19 "Sputnik V", confirming its high efficiency.
In October 2020, the head of the laboratory of the state collection of viruses at the Gamaleya Center, Inna Dolzhikova, in an interview with URA.RU, spoke about the Sputnik V vaccine against COVID-19.